Government Relations and Public Affairs

Government policy and regulation define your business environment. Understanding the political landscape in which they are made, and knowing how to navigate it, can be critical. Having the right person in your corner to advocate on your behalf can be a crucial factor in your organization’s success.

Representative experience

Advising Uber on regulatory policy issues arising from the rollout of its disruptive business model.

Advising Libyan State institutions on a range of international issues since the 2011 revolution, including engagement with UK, EU, and U.S. policymakers and legislators.

The Embassy of Japan on legislative, regulatory, policy, and other matters.

Aflac in assessing the impact of various tax reform proposals and advocating policy positions in the tax reform debate.

Nissan and advocates on their behalf on a wide variety of issues where regulatory and legislative actions may impact Nissan’s business.

Lobbying the European Commission, European Parliament, and the EU Member States on behalf of a major U.S. trade association on EU REACH-related issues.

Supported the work to gain federal approval for G2 to export natural gas from the U.S.

Advising BT Pension Scheme on formal and informal engagement with UK government, Pension Protection Fund, Pensions Regulator, and European Commission.

Provide UAS guidance to the National Association of Broadcasters.

Assisting a major international food company with an EU- and national-level lobbying strategy at aimed at ensuring the reduction of acrylamide levels in food.

Advising The Crown Estate on drafting and passage of primary and secondary legislation to give effect to the devolution of management of the Scottish estates.

Hogan Lovells Publications

Department of Defense FY18 research funding for the Congressionally Directed Medical Research Program

The Congressionally Directed Medical Research Program within the U.S. Army Medical Research and Material Command that is a partnership formed by Congress, the military and the manages...

Quick view Full view

Press Releases

Hogan Lovells advises pSivida Corp. on its acquisition of Icon Bioscience as it rebrands as EyePoint Pharmaceuticals

Philadelphia, 4 April 2018 – Hogan Lovells advised pSivida Corp. on its acquisition of Icon Bioscience, Inc. as part of its rebranding initiative into EyePoint Pharmaceuticals, Inc....

Quick view Full view


China to revamp central government and various regulators what does it all mean

Over the past weekend, the Chinese legislature decided on a major restructuring of governmental agencies.

Quick view Full view

Hogan Lovells Publications

In report to Congress, U.S. Administration identifies, but does not sanction, leading Russian oligarchs and senior government officials

On Monday, 29 January, the U.S. Treasury Department submitted an unclassified report to Congress concerning significant senior political figures and oligarchs in the Russian Federation and...

Quick view Full view

Hogan Lovells Publications

Newly published judicial interpretations on arbitration in China

On 29 December 2017, the Supreme People's Court of China (SPC) published two judicial interpretations (Interpretations) which came into force on 1 January 2018. Both Interpretations sought...

Quick view Full view

Hogan Lovells Publications

Infrastructure investment is Republicans' 2018 priority

Congress has returned from the holiday recess with renewed focus on passing a major infrastructure package in 2018. Passage of a massive tax reform bill punctuated the president's first...

Quick view Full view
Loading data